News section
home news forum careers events suppliers solutions markets resources directories advertise contacts search site plan
 
.
Advance Biological Marketing posts a record year

.

Van Wert, Ohio
July 23, 2007

Advance Biological Marketing (ABM) posted record sales at the conclusion of their fiscal year, ending June 30.

Their success is due largely to Excalibre™, the most technologically advanced soybean inoculant to hit the marketplace. Excalibre now has a 120-day post-application planting window. It was introduced to the industry in January 2006 with a 60-day, post-application planting window, which was broadened to 120 days for the 2007 planting season.

“This is the first year that ABM sold our products through distribution channels and we owe a great thanks to the regional and national distributors who helped us achieve our growth and success,” Dan Custis, ABM president, said. “ABM’s share of the soybean inoculant market nearly doubled, despite a substantial drop in U.S. soybeans planted in 2007.”

Excalibre is the only 120-day Bradyrhizobia and encapsulated soybean inoculant available to date. With these enhancements and longer shelf life, Excalibre provides agricultural seed dealers and farmers significant advantages in handling, planting and profitability.

ABM also enjoyed continued success with additional biological products, according to Marty Robinson, ABM Vice President of Sales and Marketing. “Our biological fungicide for wheat, T-22, has become the most widely used EPA registered biofungicide in U.S. field crops.”

Advanced Biological Marketing (ABM) is a Van Wert, Ohio based marketer of specialty products for production agriculture in the United States and Canada. The company’s products are some of the most advanced technologies available today. ABM is committed to educating its customers about the latest advances in agriculture. It was founded in 2000 as a privately held schedule C stock company, and is currently owned by more than 200 individual and institutional shareholders.

 

 

 

 

The news item on this page is copyright by the organization where it originated - Fair use notice

Other news from this source


Copyright © SeedQuest - All rights reserved